Xiaomi’s Munich R&D Hub Opens as Stock Sinks to a Fresh Low

Xiaomi opens Munich R&D center for European EV launch by 2027, but stock hits 52-week low amid 90% memory chip cost surge and slowing EV deliveries.

Xiaomi is sprinting in two directions at once. The Chinese tech giant just opened a research and development centre in Munich with over 100 staff, poaching engineers from BMW, Mercedes-Benz, Porsche and Lamborghini to tailor electric vehicles for European roads. Yet back in Hong Kong, the stock has hit a 52-week low of €3.30, down more than 38% from a year ago and roughly 50% below its 12-month peak of €6.69.

The disconnect between Xiaomi’s operational ambition and its market reception has rarely been starker. On the one hand, the company is laying concrete groundwork for a European EV launch in 2027, with a long-term goal of cracking the world’s top five automakers within two decades. On the other, investors are fixated on a brutal margin squeeze in its core smartphone business and a slowing EV delivery trajectory that raises questions about annual targets.

Memory chip costs crush smartphone margins

The immediate pressure point is the smartphone division. Memory chip prices surged by as much as 90% in the first quarter of 2026, hammering gross profit in the segment by more than 40% in the final quarter of 2025. Shipments fell to 33.8 million units, a year-on-year decline of roughly 19% — the steepest drop among the world’s five largest handset makers.

Xiaomi’s response has been to pivot decisively toward premium devices. In 2025, it shipped around 13.35 million premium smartphones, up 24% from the prior year. Higher average selling prices are meant to cushion an expected market contraction of at least 10% in 2026. The product cycle is also accelerating: the Xiaomi 17T and 17T Pro are now slated for the second quarter of 2026, roughly four months earlier than the traditional September window for the T-series.

EV deliveries need to pick up pace

In the electric vehicle business, Xiaomi delivered approximately 79,000 cars in the first quarter of 2026, down from more than 145,000 units in the preceding quarter. To hit the full-year target of 550,000 deliveries, the company needs to sell an average of over 52,000 vehicles per month for the remainder of the year. Demand in China still exceeds capacity at the Beijing plant, leaving production constraints as the primary bottleneck.

Buybacks fail to stem the tide

Xiaomi has been aggressive with its share repurchase programme, buying back stock worth HK$7.4 billion through the end of April — more than the entire buyback volume of the previous year. In just two trading sessions, roughly HK$200 million flowed into repurchases. None of it has arrested the downtrend.

Analyst split on AI prospects

The Munich opening coincided with a notable divergence among Wall Street analysts. Morgan Stanley argued that Xiaomi is on track to become a leading AI software company, pointing to the vertical integration of artificial intelligence across its product portfolio as a key growth driver. JP Morgan pushed back the same day, acknowledging the long-term strategy but warning that monetising the AI investments will take time.

On the software front, there are tangible advances. A new over-the-air update lowers the activation threshold for advanced driver-assistance systems from 1,000 to 300 kilometres driven. Company studies claim the systems can reduce accident rates by around 30%.

Regulatory clock ticking

The broader backdrop adds another layer of uncertainty. The EU’s AI Act comes into force on 2 August 2026, centralising oversight of AI systems and affecting planning certainty for all market participants. How quickly Xiaomi can navigate that regulatory landscape will become clear with its planned European EV launch in 2027.

The company’s annual general meeting on 2 June will see votes on amendments to improve investor protection. Before that, the board is expected to approve first-quarter results in May — a data point that could either soothe or deepen the market’s current scepticism.